Sandeep Chidambar Kulkarni, CEO at Tourmaline Bio, Inc. (TRML), bought 4,000 shares at $16.99 ($68K) on 2023-11-17, disclosed to the SEC on 2023-11-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TRML | BUY | 2023-10-26 | $111K | — | Filing → |